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Introduction
Cardiac Magnetic Resonance (CMR) can obtain accurate
information regarding ventricular function, viability, and
can also detect evidence of ischemia by myocardial per-
fusion imaging. While each of these components may
prognosticate cardiac patients from a different pathophys-
iologic perspective, we seek to determine the relative
strengths of association of each of these components of
CMR with hard cardiac events.
Purpose
We further hypothesize that evidence of myocardial
ischemia can provide incremental prognostic information
beyond LVEF and presence of myocardial scar.
Methods
We performed stress CMR on 473 patients (196 females,
mean age 56 ± 12 years) with an intermediate pre-test like-
lihood of CAD referred for assessment of myocardial
ischemia. Rest and vasodilator stress CMR myocardial per-
fusion were performed using a 0.07-0.1 mmol/Kg bolus
infusion of gadolinium, followed by cine function imag-
ing and late gadolinium enhancement (LGE) 10 minutes
after a cumulative dose of 0.15-0.2 mmol/Kg of gadolin-
ium. CMR myocardial perfusion images were interpreted
for reversible myocardial perfusion defect (RevPD) using
the 16-segment nomenclature and LGE was graded sepa-
rately. The readers were blinded to all clinical outcomes.
Results
At a median follow-up of 26.4 months (range from 3
months to 7 years), 39 major adverse cardiovascular
events (MACE) (8%) had occurred (27 cardiac deaths and
12 acute myocardial infarctions). A CMR study negative
for RevPD and LGE predicted a low negative annual event
rate for MACE (1.3%) and cardiac deaths (0.9%). By uni-
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Table 1: Univariable association with MACE in the study group
MACE (n = 39)
Variables HR HR 95% CI P
Age, years 1.06 1.03-1.09 <0.001
Female 1.01 0.64-1.09 0.986
Hypertension 3.73 1.69-8.23 0.33
Diabetes 2.6 1.38-4.93 0.003
Hx MI 2.69 1.38-4.93 0.002
Hx PCI 3.25 1.70-6.23 <0.001
LVEF, per 10% 0.95 0.93-0.97 <0.001
LC Mass Index 1.03 1.01-1.04 <0.001
LVEDVi 1.02 1.01-1.02 <0.001
LVESVi 1.01 1.01-1.03 <0.001
RWMA 5.08 2.63-9.8 <0.001
Stress perfusion defect 6.59 3.19-13.61 <0.001
RevPD 6.17 3.17-12.28 <0.001
LGE 2.67 2.63-9.8 <0.001
RevPF/LGE 5.13 2.5-10.54 <0.001Page 1 of 2
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variable analysis, the presence of RevPD and LGE por-
tended to >6-fold and >2.67-fold increase in MACE,
respectively (P < 0.001, P = 0.003) (table 1). In addition,
RevPD and LGE portended to a >4-fold increase and >3-
fold to increase in cardiac death (P < 0.001, P = 0.006),
respectively. Adjusting for age, LVEF and LGE, RevPD
maintains a strong adjusted association with MACE
(adjusted HR 4.2 P < 0.001). By stepwise forward selec-
tion strategy (table 2), considering all available variables,
RevPD persisted as a strong predictor of MACE in the best
final model.
Conclusion
Reversible myocardial perfusion as evidence of myocar-
dial ischemia provides strong and incremental prognostic
information to patients presented with an intermediate
likelihood of CAD. In addition, combining myocardial
perfusion imaging and late gadolinium enhancement
imaging, a negative CMR study portends an excellent
(99%) negative event rate for cardiac death.
Table 2: Best final model for MACE by stepwise forward 
selection
Variable Hazard Ratio P-value Chi-square
Age 1.03 0.051 3.80
Hx PCI 2.51 0.013 6.12
LVESVi 1.02 0.001 9.9
RWMA 3.62 0.016 5.71
Presence of LGE 0.21 0.007 7.28
RevPD 4.67 < 0.001 11.09
LGE = late gadolinium enhancement; Hx = history; LVEF = left 
ventricular ejection fraction; LVESVi = left ventricular end-sistolic 
volume index, LVEDVi = left ventricular end-diastoliv volume index; 
RWMA = resting wall motion abnormality and PCI = percutaneous 
coronary intervention.Page 2 of 2
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